| Literature DB >> 21074040 |
Ryan M Walsh1, Konrad Hochedlinger.
Abstract
The discovery that somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) raised the exciting possibility of modeling diseases with patient-specific cells. Marchetto et al. (2010) now use iPSC technology to generate, characterize, and treat an in vitro model for the autism spectrum disorder Rett syndrome.Entities:
Year: 2010 PMID: 21074040 PMCID: PMC3538362 DOI: 10.1016/j.cell.2010.10.037
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582